07:25 AM EST, 11/10/2025 (MT Newswires) -- Roivant Sciences ( ROIV ) reported a fiscal Q2 net loss Monday of $0.17 per diluted share, narrower than a $0.31 loss a year earlier.

Analysts polled by FactSet expected a loss of $0.32.

Revenue for the quarter ended Sept. 30 was $1.6 million, down from $4.5 million a year earlier.

Analysts surveyed by FactSet expected $5.6 million.

As of Sept. 30, the company said it had $4.40 billion in cash, cash equivalents, restricted cash and marketable securities.